Non-sterile is not un-specified.
A non-sterile product still has a number to hit and a list of organisms it must not carry. USP <61> gives you the count. USP <62> gives you the absence. We run both on the same sample, against your specification.
Two chapters, one release decision
USP <61> enumerates: total aerobic microbial count and total combined yeast and mold count, reported against the limits for your dosage form. USP <62> screens for absence: the specified organisms that disqualify a product regardless of how low the total count is. A product can pass one and fail the other, which is exactly why release testing runs both rather than treating the count as a proxy.
Choosing the right limits
USP <1111> maps recommended limits and the organism list to the route of administration and dosage form — an oral aqueous preparation, an oral solid, a herbal product and a topical each carry a different combination. We will work through that mapping with you rather than testing a default panel, so you are not paying for screens your product does not need or, worse, missing one it does.
- Escherichia coli, Salmonella species, Pseudomonas aeruginosa and Staphylococcus aureus
- Bile-tolerant Gram-negative bacteria, Candida albicans and Clostridia where the dosage form calls for them
- Presumptive positives confirmed and identified to species rather than reported as a presumptive
- Method suitability on your matrix before any routine testing begins
What you get back
- TAMC and TYMC counts reported against your release specification
- A stated result for each specified organism screened, with the method used
- Your method suitability report covering recovery and neutralization on the matrix
- Species-level confirmation of any presumptive positive, not a presumptive result
- A release-ready certificate your quality unit can sign against
The scope of microbial limits testing.
USP <61> enumeration
TAMC and TYMC by plate count or membrane filtration, reported against your release specification.
USP <62> specified organisms
Screening for E. coli, Salmonella, P. aeruginosa, S. aureus, bile-tolerant Gram-negatives, C. albicans and Clostridia.
Method suitability
Recovery proven on your actual matrix, with antimicrobial activity neutralized.
Specification setting
Help mapping USP <1111> recommended limits to your dosage form and route of administration.
Confirmatory identification
Presumptive positives confirmed and identified to species by MALDI-TOF.
Cosmetics, supplements & OTC
Routine release programs for personal care, nutraceutical and OTC monograph products.
Microbial Limits Testing, answered.
Which specified organisms do I actually need to test for?
What is method suitability and why does it come first?
Do you test cosmetics and dietary supplements?
What happens if a specified organism is detected?
How do USP <61> and <62> relate to each other?
Ready to scope your microbial limits testing?
Send us the product and the claim you need to support. We'll confirm the method, the sample count and the turnaround before anything ships.
